ANTARES PHARMA, INC. reports

Company location: Ewing, NJ
Fiscal year end: 31 December

ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 126-150 of 688 matching filings.

Per page

25

Current page

6

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2021
Reporting date: 01 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2021
Reporting date: 01 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Mar 2021
Reporting date: 01 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-32302

10-K

Filing date: 02 Mar 2021
Reporting date: 31 Dec 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32302

8-K

Filing date: 02 Mar 2021
Reporting date: 02 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Feb 2021
Reporting date: 17 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Feb 2021
Reporting date: 17 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Feb 2021
Reporting date: 18 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Feb 2021
Reporting date: 17 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Feb 2021
Reporting date: 11 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Feb 2021
Reporting date: 08 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-47575

SC 13G/A filing

Filing date: 29 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Jan 2021
Reporting date: 11 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-32302

8-K

Filing date: 11 Jan 2021
Reporting date: 11 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Nov 2020
Reporting date: 12 Nov 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-32302

8-K INVESTOR PRESENTATION

Filing date: 12 Nov 2020
Reporting date: 12 Nov 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-32302

10-Q

Filing date: 05 Nov 2020
Reporting date: 30 Sep 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32302

8-K

Filing date: 05 Nov 2020
Reporting date: 05 Nov 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32302

8-K ITEM 8.01

Filing date: 01 Oct 2020
Reporting date: 01 Oct 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32302

8-K ITEM 1.01

Filing date: 21 Sep 2020
Reporting date: 15 Sep 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-32302

10-Q

Filing date: 06 Aug 2020
Reporting date: 30 Jun 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32302

8-K ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Filing date: 06 Aug 2020
Reporting date: 06 Aug 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32302

8-K

Filing date: 16 Jun 2020
Reporting date: 11 Jun 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2020
Reporting date: 11 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2020
Reporting date: 11 Jun 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .